Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Exchange Rate Effect (2021 - 2025)

Historic Exchange Rate Effect for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $151000.0.

  • Amylyx Pharmaceuticals' Exchange Rate Effect fell 3601.69% to $151000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $431000.0, marking a year-over-year increase of 3302.47%. This contributed to the annual value of -$438000.0 for FY2024, which is 37375.0% down from last year.
  • Amylyx Pharmaceuticals' Exchange Rate Effect amounted to $151000.0 in Q3 2025, which was down 3601.69% from $608000.0 recorded in Q2 2025.
  • In the past 5 years, Amylyx Pharmaceuticals' Exchange Rate Effect registered a high of $608000.0 during Q2 2025, and its lowest value of -$525000.0 during Q4 2024.
  • Its 5-year average for Exchange Rate Effect is $36705.9, with a median of $2000.0 in 2021.
  • Over the last 5 years, Amylyx Pharmaceuticals' Exchange Rate Effect had its largest YoY gain of 553333.33% in 2022, and its largest YoY loss of 1855000.0% in 2022.
  • Quarter analysis of 5 years shows Amylyx Pharmaceuticals' Exchange Rate Effect stood at $9000.0 in 2021, then soared by 5533.33% to $507000.0 in 2022, then crashed by 53.25% to $237000.0 in 2023, then tumbled by 321.52% to -$525000.0 in 2024, then surged by 128.76% to $151000.0 in 2025.
  • Its Exchange Rate Effect stands at $151000.0 for Q3 2025, versus $608000.0 for Q2 2025 and $197000.0 for Q1 2025.